SOPHARMA AD (27/2021) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 7 June 2021.
Report no 27/2021
- 08.06.2021, 08:57
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
-
SOPHARMA AD (26/2021) Sales revenues for May 2021
Report no 26/2021- 07.06.2021, 13:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (25/2021) Notification from Simeon Donev under Art. 19 of Regulation (EU) No 596/2014 of 3 June 2021.
Report no 25/2021- 07.06.2021, 11:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (23/2021) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 3 June 2021.
Report no 23/2021- 04.06.2021, 14:30
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (22/2021) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 2 June 2021.
Report no 22/2021- 03.06.2021, 09:24
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (21/2021) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 1 June 2021.
Report no 21/2021- 02.06.2021, 11:27
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (20/2021) Annual General Meeting of Shareholders convened for 4 June 2021 from 11:00 a.m. (8:00 a.m. UTC)
Report no 20/2021- 01.06.2021, 13:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (19/2021) Consolidated financial report according to IFRS as at 31 March 2021.
Report no 19/2021- 31.05.2021, 13:32
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (18/2021) The Board of Directors of "Sopharma" AD adopted a decision to issue warrants
Report no 18/2021- 21.05.2021, 13:01
- Kategoria: Biznes i finanse
- Źródło: ESPI
